Familial CD45RA– T cells to treat severe refractory infections in immunocompromised patients

Overview of attention for article published in Frontiers in Medicine, February 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 12 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 4,312 followers.

RT @antonioper_mar: Last publication from our @L4CLaPaz group @criscancer “Familial CD45RA– T cells to treat severe refractory infections…

18 Feb 2023

Reply Repost Favourite

RT @antonioper_mar: Last publication from our @L4CLaPaz group @criscancer “Familial CD45RA– T cells to treat severe refractory infections…

10 Feb 2023

Reply Repost Favourite

RT @antonioper_mar: Last publication from our @L4CLaPaz group @criscancer “Familial CD45RA– T cells to treat severe refractory infections…

09 Feb 2023

Reply Repost Favourite

Last publication from our @L4CLaPaz group @criscancer “Familial CD45RA– T cells to treat severe refractory infections in immunocompromised patients https://t.co/zhudXlXy6M

09 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.